Cynthia investigates the application of adult human bone marrow derived mesenchymal stem cells to treat osteoarthritis. The aim of her ongoing research is to assess the combination of mesenchymal stem cells (MSCs) and growth/differentiation factor 5 (GDF-5) as a potential therapeutic for arthritis, specifically focusing on the deposition of extracellular matrix proteins.
Valerie has over 14 years experience in bioengineering research with a strong interest in carbon nanotubes for tissue engineering and regenerative medicine applications.
